止血劑市場規模、佔有率和成長分析：按產品類型、應用領域、最終用戶、分銷管道和地區分類 - 2026-2033 年行業預測

2024年全球止血劑市場價值為8.564億美元，預計將從2025年的9.1977億美元成長到2033年的16.2823億美元。預測期（2026-2033年）的複合年成長率預計為7.4%。

全球輔助止血劑市場的主要驅動力是外科手術日益複雜化以及對有效止血方案日益成長的需求。這些止血劑（包括局部用藥、貼片和密封劑）對於複雜手術中控制非壓迫性出血至關重要，尤其是在心血管外科和腫瘤外科領域。技術創新推動了止血劑從基礎材料向先進的明膠-凝血酶基質和生物密封劑的演變，提高了其療效和安全性。隨機對照試驗和真實世界臨床研究的證據表明，這些止血劑能夠減少出血併發症並縮短手術時間，這進一步推動了醫院的採購。此外，人工智慧 (AI) 在產品開發中的應用加速了材料的發現，透過針對外科醫生需求的功能性設計加快了設計流程，最終促進了止血劑在各種手術環境中的推廣應用和商業性應用。

全球止血劑市場促進因素

隨著全球外科手術數量的增加，對輔助性止血劑的需求也急劇上升。醫療專業人員和手術團隊需要有效的工具來實現快速止血、最大限度地減少術中出血並改善圍手術全期整體預後。隨著複雜微創手術的日益普及，輔助止血劑的臨床益處正被更廣泛地認可，加速了醫院和外科醫生將這些產品作為標準治療方法的採用。這種廣泛的認可促使採購量增加，並被納入藥品目錄，從而促進了常規使用。這不僅擴大了市場應用，也鼓勵對產品供應鏈和分銷網路進行持續投資。

全球止血劑市場限制因素

全球輔助止血劑市場面臨許多挑戰，例如特定產品的採購成本不斷上漲以及醫保報銷政策的不一致，這些都會影響醫院的採購決策。在醫療成本控制日益嚴格的環境下，由於缺乏明確的支付方支持，採購委員會往往優先考慮成本較低的替代方案和標準做法。這種抵抗情緒阻礙了輔助止血劑的頻繁使用，並延緩了其在臨床通訊協定中的應用。因此，儘管臨床獲益使其具有更高的使用潛力，但由於重複購買率下降和市場滲透率有限，市場成長受到抑制。

全球止血劑市場趨勢

受微創外科技術廣泛應用的推動，全球輔助止血劑市場正經歷重大變革時期。隨著外科手術技術的進步，人們對能夠在狹小空間內提供卓越止血效果、快速控制出血並能適應複雜解剖結構的止血劑的需求日益成長。這一趨勢推動了稀薄、液態和噴霧型止血劑以及專用施用器的研發，這些塗抹器能夠與先進的手術器械無縫整合。製造商正在改進產品包裝、提供培訓解決方案並最佳化相容性，以滿足外科醫生的需求。預計這將促進止血劑在各個外科專科領域的更廣泛應用。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系圖譜
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢

全球止血劑市場規模：依產品類型及複合年成長率（2026-2033 年）分類

• 凝膠型止血劑
• 泡沫型止血劑
• 纖維基止血劑

全球止血劑市場規模：按應用和複合年成長率分類（2026-2033 年）

• 外科手術
  • 整形外科手術
  • 心血管外科
• 創傷病例

全球止血劑市場規模：依最終用戶和複合年成長率分類（2026-2033 年）

• 醫院
• 門診手術中心
• 診所

全球止血劑市場規模：按分銷管道和複合年成長率分類（2026-2033 年）

• 直銷
• 線上銷售
• 銷售代理

全球止血劑市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Johnson & Johnson
• Baxter International
• Medtronic
• CR Bard
• Ethicon
• Integra LifeSciences
• Stryker Corporation
• ZymoGenetics
• Hemostasis LLC
• Anika Therapeutics
• Acelity
• Tissuemed
• CryoLife
• Plexus Biomedical
• Biometrix
• Cohera Medical
• Revive Surgical
• Haemostatic Technologies
• Arthrex
• Sientra

結論與建議

Global Adjunctive Hemostats Market size was valued at USD 856.4 Million in 2024 and is poised to grow from USD 919.77 Million in 2025 to USD 1628.23 Million by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The Global Adjunctive Hemostats Market is primarily driven by the increasing complexity of surgical procedures and the growing demand for effective bleeding control solutions. These hemostatic agents, including topical applications, patches, and sealants, are crucial in managing non-compressible bleeding during intricate surgeries, particularly in cardiovascular and oncologic contexts. Innovations have evolved from basic materials to advanced gelatin-thrombin matrices and biological sealants, enhancing their efficacy and safety. Evidence from randomized trials and real-world studies showcasing reduced bleeding complications and shorter operation times further propel hospital procurement. Additionally, the integration of artificial intelligence (AI) in product development enhances material discovery and accelerates the design process by tailoring features to surgeon needs, ultimately facilitating easier adoption and commercial opportunities across diverse surgical settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Adjunctive Hemostats market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Adjunctive Hemostats Market Segments Analysis

Global adjunctive hemostats market is segmented by product type, application area, end user, distribution channel and region. Based on product type, the market is segmented into Gel-based Hemostats, Foam-based Hemostats and Fiber-based Hemostats. Based on application area, the market is segmented into Surgical Procedures and Trauma Cases. Based on end user, the market is segmented into Hospitals, Ambulatory Surgery Centers and Clinics. Based on distribution channel, the market is segmented into Direct Sales, Online Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Adjunctive Hemostats Market

The growing volume of surgical procedures worldwide significantly boosts the demand for adjunctive hemostats, as healthcare professionals and surgical teams require effective tools to attain swift hemostasis, minimize intraoperative bleeding, and enhance overall perioperative results. With the increasing prevalence of complex and minimally invasive surgeries, the clinical advantages of adjunctive hemostats are becoming more recognized, prompting hospitals and surgeons to adopt these products into standard care practices. This widespread acceptance leads to greater procurement and formulary inclusion, resulting in routine usage that not only broadens market adoption but also encourages ongoing investment in product availability and distribution networks.

Restraints in the Global Adjunctive Hemostats Market

The Global Adjunctive Hemostats market faces challenges due to elevated acquisition costs for specific products and inconsistent reimbursement policies that affect purchasing decisions within hospitals. In cost-sensitive healthcare environments, lack of clear support from payers for additional product expenses leads procurement committees to favor lower-cost alternatives or standard practices. This reluctance hinders the frequent use of adjunctive hemostats and slows their integration into clinical protocols. Consequently, the market growth is impeded as repeat purchases wane and broader market penetration is restricted, despite the potential clinical benefits that could drive increased utilization.

Market Trends of the Global Adjunctive Hemostats Market

The Global Adjunctive Hemostats market is experiencing a significant shift driven by the increasing adoption of minimally invasive surgical techniques. As surgical practices evolve, there is a growing demand for hemostatic agents that excel in constrained environments, offering rapid bleeding control and the ability to adapt to complex anatomical structures. This trend is propelling the development of low-profile, flowable, and sprayable hemostats, along with specialized applicators designed for seamless integration with advanced surgical instruments. Manufacturers are enhancing product packaging, providing training solutions, and optimizing compatibility to align with surgeon preferences, ultimately facilitating broader acceptance and application across diverse surgical specialties.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Adjunctive Hemostats Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Gel-based Hemostats
• Foam-based Hemostats
• Fiber-based Hemostats

Global Adjunctive Hemostats Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Surgical Procedures
  • Orthopedic Surgeries
  • Cardiovascular Surgeries
• Trauma Cases

Global Adjunctive Hemostats Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers
• Clinics

Global Adjunctive Hemostats Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Online Sales
• Distributors

Global Adjunctive Hemostats Market Size & CAGR (2026-2033)

• North America (Product Type, Application Area, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Application Area, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application Area, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application Area, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application Area, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.R. Bard
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZymoGenetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemostasis LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acelity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissuemed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Plexus Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biometrix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revive Surgical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemostatic Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sientra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations